TLR regulation of SPSB1 controls inducible nitric oxide synthase induction

Journal of Immunology

Volumn 187, Issue 7, 2011, Pages 3798-3805

  Lewis, Rowena S ^a   Kolesnik, Tatiana B ^a   Kuang, Zhihe ^a   D'Cruz, Akshay A ^a,b   Blewitt, Marnie E ^a   Masters, Seth L ^a   Low, Andrew ^a   Willson, Tracy ^a   Norton, Raymond S ^a,c   Nicholson, Sandra E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEASOME; PROTEIN SPSB1; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME REGULATION; GENE SILENCING; IMMUNOREGULATION; MACROPHAGE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, WESTERN; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MACROPHAGES; MICE; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTORS;

EID: 80053491919     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002993     Document Type: Article

References (58)

1. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13: 816-825.
2. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376. (Pubitemid 37174535)
3. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
4. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
5. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364. (Pubitemid 46674493)
6. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4: 161-167. (Pubitemid 36193018)
7. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643. (Pubitemid 36927946)
8. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672. (Pubitemid 36899248)
9. Alderton, W. K., C. E. Cooper, and R. G. Knowles. 2001. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357: 593-615. (Pubitemid 32735142)
10. Knowles, R. G., and S. Moncada. 1994. Nitric oxide synthases in mammals. Biochem. J. 298: 249-258. (Pubitemid 24072462)
11. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350. (Pubitemid 27169284)
12. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918. (Pubitemid 24292319)
13. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173: 17-26. (Pubitemid 30095207)
14. Chakravortty, D., and M. Hensel. 2003. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 5: 621-627. (Pubitemid 36645122)
15. Kröncke, K. D., K. Fehsel, and V. Kolb-Bachofen. 1998. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113: 147-156. (Pubitemid 28352831)
16. Kolodziejski, P. J., J. S. Koo, and N. T. Eissa. 2004. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc. Natl. Acad. Sci. USA 101: 18141-18146. (Pubitemid 40054087)
17. Kolodziejski, P. J., A. Musial, J. S. Koo, and N. T. Eissa. 2002. Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc. Natl. Acad. Sci. USA 99: 12315-12320.
18. Musial, A., and N. T. Eissa. 2001. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J. Biol. Chem. 276: 24268-24273.
19. Kuang, Z., R. S. Lewis, J. M. Curtis, Y. Zhan, B. M. Saunders, J. J. Babon, T. B. Kolesnik, A. Low, S. L. Masters, T. A. Willson, et al. 2010. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation. J. Cell Biol. 190: 129-141.
20. Kamura, T., S. Sato, D. Haque, L. Liu, W. G. Kaelin, Jr., R. C. Conaway, and J. W. Conaway. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12: 3872-3881. (Pubitemid 29024849)
21. Zhang, J. G., D. Metcalf, S. Rakar, M. Asimakis, C. J. Greenhalgh, T. A. Willson, R. Starr, S. E. Nicholson, W. Carter, W. S. Alexander, et al. 2001. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98: 13261-13265. (Pubitemid 33051350)
22. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67: 425-479. (Pubitemid 28411135)
23. Petroski, M. D., and R. J. Deshaies. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6: 9-20. (Pubitemid 40064895)
24. Hilton, D. J., R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf, and N. A. Nicola. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95: 114-119. (Pubitemid 28103916)
25. Nicholson, S. E., and D. J. Hilton. 1998. The SOCS proteins: a new family of negative regulators of signal transduction. J. Leukoc. Biol. 63: 665-668. (Pubitemid 28274826)
26. Woo, J. S., H. Y. Suh, S. Y. Park, and B. H. Oh. 2006. Structural basis for protein recognition by B30.2/SPRY domains. Mol. Cell 24: 967-976.
27. Kuang, Z., S. Yao, Y. Xu, R. S. Lewis, A. Low, S. L. Masters, T. A. Willson, T. B. Kolesnik, S. E. Nicholson, T. J. Garrett, and R. S. Norton. 2009. SPRY domain-containing SOCS box protein 2: crystal structure and residues critical for protein binding. J. Mol. Biol. 386: 662-674.
28. Filippakopoulos, P., A. Low, T. D. Sharpe, J. Uppenberg, S. Yao, Z. Kuang, P. Savitsky, R. S. Lewis, S. E. Nicholson, R. S. Norton, and A. N. Bullock. 2010. Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4. J. Mol. Biol. 401: 389-402.
29. Masters, S. L., S. Yao, T. A. Willson, J. G. Zhang, K. R. Palmer, B. J. Smith, J. J. Babon, N. A. Nicola, R. S. Norton, and S. E. Nicholson. 2006. The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues. Nat. Struct. Mol. Biol. 13: 77-84. (Pubitemid 43049406)
30. Masters, S. L., K. R. Palmer, W. S. Stevenson, D. Metcalf, E. M. Viney, N. S. Sprigg, W. S. Alexander, N. A. Nicola, and S. E. Nicholson. 2005. Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia. Mol. Cell. Biol. 25: 5639-5647. (Pubitemid 40853598)
31. Wormald, S., J. G. Zhang, D. L. Krebs, L. A. Mielke, J. Silver, W. S. Alexander, T. P. Speed, N. A. Nicola, and D. J. Hilton. 2006. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281: 11135-11143. (Pubitemid 43855538)
32. Nicholson, S. E., U. Novak, S. F. Ziegler, and J. E. Layton. 1995. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 86: 3698-3704.
33. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543-1555. (Pubitemid 19126814)
34. Paddison, P. J., M. Cleary, J. M. Silva, K. Chang, N. Sheth, R. Sachidanandam, and G. J. Hannon. 2004. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat. Methods 1: 163-167.
35. Dickins, R. A., M. T. Hemann, J. T. Zilfou, D. R. Simpson, I. Ibarra, G. J. Hannon, and S. W. Lowe. 2005. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37: 1289-1295. (Pubitemid 41568715)
36. Dickins, R. A., K. McJunkin, E. Hernando, P. K. Premsrirut, V. Krizhanovsky, D. J. Burgess, S. Y. Kim, C. Cordon-Cardo, L. Zender, G. J. Hannon, and S. W. Lowe. 2007. Tissue-specific and reversible RNA interference in transgenic mice. Nat. Genet. 39: 914-921. (Pubitemid 47014488)
37. Majewski, I. J., M. E. Blewitt, C. A. De Graaf, E. J. McManus, M. Bahlo, A. A. Hilton, C. D. Hyland, G. K. Smyth, J. E. Corbin, D. Metcalf, et al. 2008. Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol. 6: e93.
38. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178: 605-613. (Pubitemid 23218209)
39. Finder, J.,W.W. Stark, Jr., D. K.Nakayama, D.Geller, K.Wasserloos, B. R. Pitt, and P. Davies. 1995. TGF-beta regulates production of NO in pulmonary artery smooth muscle cells by inhibiting expression of NOS. Am. J. Physiol. 268: L862-L867.
40. Schini, V. B., W. Durante, E. Elizondo, T. Scott-Burden, D. C. Junquero, A. I. Schafer, and P. M. Vanhoutte. 1992. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells. Eur. J. Pharmacol. 216: 379-383.
41. Ashkar, A. A., K. L. Mossman, B. K. Coombes, C. L. Gyles, and R. Mackenzie. 2008. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 4: e1000233.
42. Guo, B., and G. Cheng. 2007. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282: 11817-11826. (Pubitemid 47100710)
43. McWhirter, S. M., K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock, and T. Maniatis. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101: 233-238. (Pubitemid 38084233)
44. Chang, M., W. Jin, and S. C. Sun. 2009. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 10: 1089-1095.
45. Akaike, T., and H. Maeda. 2000. Nitric oxide and virus infection. Immunology 101: 300-308.
46. Zaragoza,C.,C. J.Ocampo,M.Saura,A.McMillan, andC. J. Lowenstein. 1997. Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Invest. 100: 1760-1767. (Pubitemid 27431333)
47. Lin,Y. L.,Y. L.Huang, S. H. Ma, C. T.Yeh, S.Y. Chiou, L.K. Chen, and C. L. Liao. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71: 5227-5235.
48. Fujikura, Y., P. Kudlackova, M. Vokurka, J. Krijt, and Z. Melkova. 2009. The effect of nitric oxide on vaccinia virus-encoded ribonucleotide reductase. Nitric Oxide 20: 114-121.
49. Harris, N., R.M. Buller, and G. Karupiah. 1995. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69: 910-915.
50. Ming, M., M. E. Ewen, and M. E. Pereira. 1995. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell 82: 287-296.
51. Barral, A., M. Barral-Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90: 3442-3446. (Pubitemid 23111382)
52. Taniguchi, H., N. Kato, M. Otsuka, T. Goto, H. Yoshida, Y. Shiratori, and M. Omata. 2004. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J. Med. Virol. 72: 52-59. (Pubitemid 37484743)
53. Chen, S., D. L. Tuttle, J. T. Oshier, H. J. Knot, W. J. Streit, M. M. Goodenow, and J. K. Harrison. 2005. Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology 114: 565-574. (Pubitemid 40478150)
54. Cnop, M., N. Welsh, J. C. Jonas, A. Jörns, S. Lenzen, and D. L. Eizirik. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2): S97-S107. (Pubitemid 43343337)
55. Nathan, C., N. Calingasan, J. Nezezon, A. Ding, M. S. Lucia, K. La Perle, M. Fuortes, M. Lin, S. Ehrt, N. S. Kwon, et al. 2005. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202: 1163-1169. (Pubitemid 41586946)
56. Colton, C. A., R. T. Mott, H. Sharpe, Q. Xu, W. E. Van Nostrand, and M. P. Vitek. 2006. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 3: 27.
57. Prado, C. M., E. A. Leick-Maldonado, L. Yano, A. S. Leme, V. L. Capelozzi, M. A. Martins, and I. F. Tibério. 2006. Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am. J. Respir. Cell Mol. Biol. 35: 457-465. (Pubitemid 44479728)
58. Xiong, Q., Y. Tezuka, T. Kaneko, H. Li, L. Q. Tran, K. Hase, T. Namba, and S. Kadota. 2000. Inhibition of nitric oxide by phenylethanoids in activated macrophages. Eur. J. Pharmacol. 400: 137-144. (Pubitemid 30412119)